Cargando…

Integrating immune checkpoint inhibitors and targeted therapies in the treatment of early stage non-small cell lung cancer: a narrative review

Prognosis of early stage non-small cell lung cancer (eNSCLC) is poor even when treated radically with surgery and (neo)adjuvant chemotherapy (Cht). The discovery of tyrosine kinase inhibitors (TKIs) for oncogene addicted NSCLC and immune checkpoint inhibitors (ICIs) have revolutionised the therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ortega-Franco, Ana, Calvo, Virginia, Franco, Fabio, Provencio, Mariano, Califano, Raffaele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Review Article on Looking for Chimeras in NSCLC: Widen Therapeutic Options Targeting Oncogenic Fusions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815374/ https://www.ncbi.nlm.nih.gov/pubmed/33489825 http://dx.doi.org/10.21037/tlcr-20-546

Ejemplares similares

Targeting chimeras fusion proteins in non-small cell lung cancer: where are we going?
por: Passiglia, Francesco, et al.
Publicado: (2020)

Is there any place for immune-checkpoint inhibitors in the treatment algorithm of fusion-driven non-small cell lung cancer?—a literature review
por: Leone, Gianmarco, et al.
Publicado: (2020)

Narrative review of molecular pathways of kinase fusions and diagnostic approaches for their detection in non-small cell lung carcinomas
por: Matter, Matthias S., et al.
Publicado: (2020)

Resistance to anaplastic lymphoma kinase inhibitors: knowing the enemy is half the battle won
por: Tabbò, Fabrizio, et al.
Publicado: (2020)

Overcoming TKI resistance in fusion-driven NSCLC: new generation inhibitors and rationale for combination strategies
por: Russo, Alessandro, et al.
Publicado: (2020)

Central nervous system metastases and oligoprogression during treatment with tyrosine kinase inhibitors in oncogene-addicted non-small cell lung cancer: how to treat and when?
por: Schoenmaekers, Janna Josephus Anna Oda, et al.
Publicado: (2020)

Future perspectives from lung cancer pre-clinical models: new treatments are coming?
por: Bersani, Francesca, et al.
Publicado: (2020)

The role of plasma genotyping in ALK- and ROS1-rearranged lung cancer
por: Dagogo-Jack, Ibiayi, et al.
Publicado: (2020)

Decade in review: a new era for RET-rearranged lung cancers
por: Choudhury, Noura J., et al.
Publicado: (2020)

How to select the best upfront therapy for metastatic disease? Focus on ALK-rearranged non-small cell lung cancer (NSCLC)
por: Xia, Bing, et al.
Publicado: (2020)

How selecting best therapy for metastatic NTRK fusion-positive non-small cell lung cancer?
por: Ekman, Simon
Publicado: (2020)

Emerging oncogenic fusions other than ALK, ROS1, RET, and NTRK in NSCLC and the role of fusions as resistance mechanisms to targeted therapy
por: Suda, Kenichi, et al.
Publicado: (2020)

How selecting best upfront therapy for metastatic disease?—Focus on ROS1-rearranged disease
por: Landi, Lorenza, et al.
Publicado: (2020)

Complications with axial presacral lumbar interbody fusion: A 5-year postmarketing surveillance experience
por: Gundanna, Mukund I., et al.
Publicado: (2011)

Cost comparison of patients with 3-level artificial total lumbar disc replacements versus 360° fusion at 3 contiguous lumbar vertebral levels: an analysis of compassionate use at 1 site of the US investigational device exemption clinical trial
por: Buttacavoli, Frank A., et al.
Publicado: (2010)

Anterior Cervical Corpectomy and Fusion Accelerates Degenerative Disease at Adjacent Vertebral Segments
por: Pickett, Gwynedd E., et al.
Publicado: (2008)

179P Efficacy and safety of extended-interval dosing strategy of immune checkpoint inhibitors during the COVID-19 outbreak: Experience from a single center
por: Pierre, C., et al.
Publicado: (2021)

miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase Cδ
por: Gentilin, Erica, et al.
Publicado: (2013)

180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19
por: Cui, W., et al.
Publicado: (2021)

182P Impact of SARS CoV 2 outbreak in the molecular diagnosis of advanced NSCLC: A retrospective comparative cohort study
por: Marin, E., et al.
Publicado: (2021)

Eye health in the future: what are the challenges for the next twenty years?
por: Taylor, Hugh R
Publicado: (2008)

Overlap of Autism and Seizures: Understanding Cognitive Comorbidity
por: Khetrapal, Neha
Publicado: (2010)

The ICMJE and URM: Providing Independent Advice for the Conduct of Biomedical Research and Publication
por: Van der Weyden, Martin B
Publicado: (2007)

A Look at CMAJ: A Misty Image Indeed
Publicado: (2006)

Are Jews Smarter Than Everyone Else?
por: Gilman, Sander L.
Publicado: (2008)

My Close Friends Lurk All Around The House, And He Knows Not!
por: Singh, Shakuntala A.
Publicado: (2009)

From Here and Now to Infinity and Eternity: A Message to New Medical Doctors(*)
por: Lapeña, José Florencio F.
Publicado: (2014)

A Ballad for the Bald!
por: Srinivas, B
Publicado: (2015)

The Allan Burns mummies: A history and future prospect of an anatomical collection
por: Lee, J, et al.
Publicado: (2017)

Black Looks....at Risks
por: Black, Douglas
Publicado: (1991)

Black Looks... at Literacy
por: Black, Douglas
Publicado: (1991)

Black Looks... at 'Population Medicine'
por: Black, Douglas
Publicado: (1991)

Black Looks... at Inducements
por: Black, Douglas
Publicado: (1991)

Black Looks... at Paternalism
por: Black, Douglas
Publicado: (1993)

Black Looks... at Audit
por: Black, Douglas
Publicado: (1993)

Black Looks... at Habits
por: Black, Douglas
Publicado: (1993)

Black Looks... Back... and Ahead
por: Black, Douglas
Publicado: (1993)

Black Looks ... at 'Isms'
por: Black, Douglas
Publicado: (1992)

Black Looks ... at Prevention and Cure
por: Black, Douglas
Publicado: (1992)

Black Looks ... at Elections
por: Black, Douglas
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_q3oiik4mnbdnq6t7khf1r1g72t